Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

BACKGROUND: The role of dysglycemia as an additional risk factor for atrial fibrillation (AF) is controversial. Therefore, it was of interest to assess risk factors for incident AF in a large, representative population of patients with cardiovascular risk factors and impaired glucose tolerance but...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Latini, R, Staszewsky, L, Sun, J, Bethel, M, Disertori, M, Haffner, S, Holman, R, Chang, F, Giles, T, Maggioni, A, Rutten, G, Standl, E, Thomas, L, Tognoni, G, Califf, R, McMurray, J
التنسيق:	Journal article
اللغة:	English
منشور في:	2013

مواد مشابهة

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
حسب: Preiss, D, وآخرون
منشور في: (2013)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
حسب: Califf, R, وآخرون
منشور في: (2008)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
حسب: Preiss, D, وآخرون
منشور في: (2012)

Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
حسب: Mcmurray, J, وآخرون
منشور في: (2011)

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
حسب: Krum, H, وآخرون
منشور في: (2010)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
حسب: Currie, G, وآخرون
منشور في: (2017)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
حسب: Sharma, A, وآخرون
منشور في: (2016)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk
حسب: Bethel, M, وآخرون
منشور في: (2013)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
حسب: Bethel, M, وآخرون
منشور في: (2013)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
حسب: Yates, T, وآخرون
منشور في: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
حسب: Yates, T, وآخرون
منشور في: (2014)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
حسب: Anke Tönjes, وآخرون
منشور في: (2010-01-01)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
حسب: Califf, R, وآخرون
منشور في: (2003)

Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
حسب: Shen, L, وآخرون
منشور في: (2012)

Study of Impaired Glucose Tolerance in Pulmonary Tuberculosis
حسب: Jain MK, وآخرون
منشور في: (2006-01-01)

Impaired glucose tolerance in sleep disorders.
حسب: Marietta Keckeis, وآخرون
منشور في: (2010-03-01)

Evaluation of a self-administered oral glucose tolerance test
حسب: Bethel, M, وآخرون
منشور في: (2013)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
حسب: Yupu Liu, وآخرون
منشور في: (2022-02-01)

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
حسب: Shen, L, وآخرون
منشور في: (2013)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
حسب: Hermans, M, وآخرون
منشور في: (1996)

Diet and other health-related behaviors of individuals with impaired glucose tolerance, cardiovascular disease (CVD) or CVD risk: A global view from the NAVIGATOR study
حسب: Bales, C, وآخرون
منشور في: (2013)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
حسب: Gerstein, H, وآخرون
منشور في: (2006)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
حسب: Holman, R
منشور في: (1996)

Impaired glucose tolerance: who and how treats it?
حسب: M. N. Mamedov
منشور في: (2005-12-01)

Florid diabetic complications in impaired glucose tolerance
حسب: Anil P Bhatt, وآخرون
منشور في: (2013-01-01)

Impaired glucose tolerance with neurological manifestations in insulinoma
حسب: Luis Geraldine Villanueva‐Rodríguez, وآخرون
منشور في: (2021-09-01)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
حسب: Yutaka Inoue, وآخرون
منشور في: (2022-06-01)

Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach
حسب: Theodorakis, M, وآخرون
منشور في: (2016)

SERUM URIC ACID LEVEL IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE AS COMPARED TO SUBJECTS WITH NORMAL GLUCOSE TOLERANCE
حسب: Muhammad Zubair, وآخرون
منشور في: (2019-10-01)

Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance
حسب: Wascher Thomas C, وآخرون
منشور في: (2006-04-01)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
حسب: Wamil, M, وآخرون
منشور في: (2020)

Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance
حسب: Sae Aoyama-Sasabe, وآخرون
منشور في: (2016-01-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
حسب: Nihar Ranjan Mohanty, وآخرون
منشور في: (2022-06-01)

Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance
حسب: Eugene Han, وآخرون
منشور في: (2020-06-01)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
حسب: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
منشور في: (2012-01-01)

The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
حسب: Mohanlal, N, وآخرون
منشور في: (2002)

Early detection of impaired glucose tolerance in young adults
حسب: May, Khin Soe, وآخرون
منشور في: (2013)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
حسب: Susanne Andersson, وآخرون
منشور في: (2011-01-01)

Subclinical hypothyroidism and impaired glucose tolerance during pregnancy
حسب: Wen-Ling Lee, وآخرون
منشور في: (2023-01-01)

Oxidative injury and neuropathy in diabetes and impaired glucose tolerance
حسب: James W. Russell, وآخرون
منشور في: (2008-06-01)